Structure-based drug design: combinatorial chemistry and molecular modeling.

Area of Science:

• Medicinal Chemistry and Computational Drug Design

Background:

• Drug discovery increasingly utilizes combinatorial chemistry and rational library design.
• Computational methods offer novel approaches for identifying lead compounds and designing virtual libraries for screening.

Purpose of the Study:

• To provide an overview of current library generation methodologies.
• To highlight the utility of docking procedures in drug discovery and optimization.

Main Methods:

• Review of computational methods for library generation.
• Focus on docking procedures for lead compound identification and optimization.
• Presentation of three case studies using docking: human A3 adenosine receptor inhibitors, HIV-1 protease inhibitors, and human thioredoxin inhibitors.

Main Results:

• Docking procedures are valuable tools in both the discovery and optimization phases of drug development.
• Demonstrated application of docking in developing inhibitors for specific biological targets.
• Successful evaluation of novel inhibitors using docking-based approaches.

Conclusions:

• Docking methodologies significantly contribute to efficient drug discovery pipelines.
• The presented examples showcase the versatility and effectiveness of docking in targeting various proteins.
• Computational approaches, particularly docking, are essential for modern drug development.